[HTML][HTML] Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study
Introduction This study characterizes patients receiving evolocumab in clinical practice and
assesses treatment effectiveness, safety and persistence outcomes across five countries …
assesses treatment effectiveness, safety and persistence outcomes across five countries …
Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study.
M Gupta, RJ Wani, K Al Faraidy… - Cardiology & …, 2023 - search.ebscohost.com
Introduction: This study characterizes patients receiving evolocumab in clinical practice and
assesses treatment effectiveness, safety and persistence outcomes across five countries …
assesses treatment effectiveness, safety and persistence outcomes across five countries …
Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study.
M Gupta, RJ Wani, K Al Faraidy, J Bergeron… - Cardiology and …, 2023 - europepmc.org
Methods This retrospective and prospective observational study enrolled patients initiated
on evolocumab during August 2017 to July 2019 at 49 sites across Canada, Mexico …
on evolocumab during August 2017 to July 2019 at 49 sites across Canada, Mexico …
[HTML][HTML] Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study
M Gupta, RJ Wani, K Al Faraidy, J Bergeron… - Cardiology and …, 2023 - ncbi.nlm.nih.gov
Methods This retrospective and prospective observational study enrolled patients initiated
on evolocumab during August 2017 to July 2019 at 49 sites across Canada, Mexico …
on evolocumab during August 2017 to July 2019 at 49 sites across Canada, Mexico …
Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study
M Gupta, RJ Wani, K Al Faraidy… - Cardiology and …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction This study characterizes patients receiving evolocumab in clinical practice and
assesses treatment effectiveness, safety and persistence outcomes across five countries …
assesses treatment effectiveness, safety and persistence outcomes across five countries …
Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study.
M Gupta, RJ Wani, K Al Faraidy, J Bergeron… - Cardiology and …, 2023 - europepmc.org
Methods This retrospective and prospective observational study enrolled patients initiated
on evolocumab during August 2017 to July 2019 at 49 sites across Canada, Mexico …
on evolocumab during August 2017 to July 2019 at 49 sites across Canada, Mexico …